Popular / View All Posts

Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis...

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

| Acne, Featured Articles, Latest News, Medical Derm | No Comments
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose...
Journal of Drugs in Dermatology JDD Article about The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States

The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States

| Derm Community, Featured Articles, Latest News, Skin of Color | No Comments
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx...

2025 JDD Welcome Kit

| Featured Articles, Home page feature, JDD Higlights | No Comments
Now arrived for recently graduated dermatologists: the JDD Welcome Kit! The Journal of Drugs in Dermatology (JDD), together with generous sponsors, has sent these curated kits to the newest members...